Formic Acid

Formic Acid

SCHEMBL6324510

CCCNCc1cc(OC)cc(OC)c1.O=CO

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
HDAC3 O15379 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
MARS1 P56192 2/20 0.44
HIF1A Q16665 1/20 0.43
KDM4E B2RXH2 3/20 0.43
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CHRM2 P08172 1/20 0.43
ALDH1A1 P00352 2/20 0.42
CNR1 P21554 2/20 0.42
CNR2 P34972 1/20 0.42
HTT P42858 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13330470 0.91 MEN1 (0.49) MEN1KMT2AHDAC3HDAC1HDAC2
SCHEMBL8436952 0.82 CHRM2 (0.53) MEN1KMT2AHDAC3HDAC1HDAC2
SCHEMBL25471395 0.80 HTR2A (0.47) MEN1KMT2AKDM4ETSHRSMN1; SMN2
Hydrochloric Acid SCHEMBL8432474 0.80 MEN1 (0.51) MEN1KMT2AHDAC3HDAC1HDAC2
Formic Acid SCHEMBL5072954 0.79 MEN1 (0.49) MEN1KMT2AHDAC3HDAC1HDAC2
SCHEMBL12963417 0.76 MEN1 (0.51) MEN1KMT2AHDAC3HDAC1HDAC2
SCHEMBL9832247 0.75 SMN1; SMN2 (0.50) MEN1KMT2AHDAC3HDAC1HDAC2
SCHEMBL10384415 0.75 CHRM2 (0.73) MEN1KMT2AHDAC1KDM4ESMN1; SMN2
SCHEMBL3544426 0.74 KMT2A (0.51) MEN1KMT2AHDAC3HDAC1HDAC2
Formic Acid SCHEMBL6325278 0.74 KDM4E (0.58) MEN1KMT2AKDM4ETSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501830-A1 7-ARYL-3,9-DIAZABICYCLO[3.3.1]NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES Actelion Pharmaceuticals Ltd. (CH) 2005-02-02 EP disclosed
WO-2003093267-A1 7-ARYL-3,9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES ACTELION PHARMACEUTICALS LTD (CH) 2003-11-13 WO disclosed